Editor’s Choice-Medically managed patients with non–ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease

European Heart Journal: Acute Cardiovascular Care

Volumn 6, Issue 3, 2017, Pages 262-271

  Feldman, Laurent ^a,b,c,d   Steg, Philippe G ^a,b,c,d,e   Amsallem, Myriam ^a   Puymirat, Etienne ^b,d,f   Sorbets, Emmanuel ^a,c,d   Elbaz, Meyer ^d,g   Ritz, Bernard ^h   Hueber, Arnaud ⁱ   Cattan, Simon ^d,j   Piot, Christophe ^k   Ferrières, Jean ^g   Simon, Tabassome ^c,d,l,m   Danchin, Nicolas ^b,d,f,m  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d French Alliance for Cardiovascular Clinical Trials   (France)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g CHU RANGUEIL   (France)

^h CENTRE HOSPITALIER SAINT JOSEPH SAINT LUC   (France)

ⁱ Clinique Claude Bernard   (France)

^j Cardiology Department   (France)

^k Clinique Du Millenaire   (France)

^l HÔPITAL SAINT ANTOINE   (France)

^m SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

angiography; medical management; myocardial infarction; Non ST elevation acute coronary syndrome; revascularization

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL OUTCOME; CLINICAL TRIAL (TOPIC); CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL PROCEDURES; MORTALITY RATE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROGNOSIS; VERY ELDERLY; DIAGNOSTIC IMAGING; HOSPITAL ADMISSION; MIDDLE AGED; MORTALITY; PROCEDURES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; NON-ST ELEVATED MYOCARDIAL INFARCTION; PATIENT ADMISSION; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 85050579516     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872615626354     Document Type: Article

References (26)

1. Amsterdam EA, Wenger NK, Brindis RG. 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130: e344–e426.
2. Hamm CW, Bassand JP, Agewall S. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999–3054.
3. Alfredsson J, Lindback J, Wallentin L. Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes: From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Eur Heart J 2011; 32: 3128–3136.
4. Amsterdam EA, Peterson ED, Ou FS. Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative. Am Heart J 2009; 158: 748–754.
5. Fox KA, Steg PG, Eagle KA. Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 2007; 297: 1892–1900.
6. Held C, Tricoci P, Huang Z. Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: Results from the TRACER trial. Eur Heart J Acute Cardiovasc Care 2014; 3: 246–256.
7. Lindholm D, Varenhorst C, Cannon CP. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: Results from the PLATO trial. Eur Heart J 2014; 35: 2083–2093.
8. Yusuf S, Mehta SR, Chrolavicius S. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006; 354: 1464–1476.
9. Chan MY, Mahaffey KW, Sun LJ. Prevalence, predictors, and impact of conservative medical management for patients with non–ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease. JACC Cardiovasc Interv 2008; 1: 369–378.
10. Roe MT, White JA, Kaul P. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: Insights from the EARLY ACS trial. Circ Cardiovasc Qual Outcomes 2012; 5: 205–213.
11. Bhatt DL, Roe MT, Peterson ED. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative. JAMA 2004; 292: 2096–2104.
12. Goto K, Lansky AJ, Fahy M. Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: An Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy. Circulation 2010; 121: 853–862.
13. Roe MT, Armstrong PW, Fox KA. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med 2012; 367: 1297–1309.
14. Danchin N, Coste P, Ferrieres J. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: Data from the French Registry on Acute ST-elevation Myocardial Infarction (FAST-MI). Circulation 2008; 118: 268–276.
15. Puymirat E, Taldir G, Aissaoui N. Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome). JACC Cardiovasc Interv 2012; 5: 893–902.
16. Yeh RW, Sidney S, Chandra M. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010; 362: 2155–2165.
17. Fox KA, Carruthers KF, Dunbar DR. Underestimated and under-recognized: The late consequences of acute coronary syndrome (GRACE UK-Belgian Study). Eur Heart J 2010; 31: 2755–2764.
18. Chan MY, Sun JL, Newby LK. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation 2009; 119: 3110–3117.
19. Fox KA, Anderson FA, Jr. Dabbous OH. Intervention in acute coronary syndromes: Do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 2007; 93: 177–182.
20. Wiviott SD, White HD, Ohman EM. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: A secondary, prespecified analysis of the TRILOGY ACS trial. Lancet 2013; 382: 605–613.
21. Patel MR, Chen AY, Peterson ED. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative. Am Heart J 2006; 152: 641–647.
22. Steg PG, Greenlaw N, Tendera M. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: Data from the International Observational CLARIFY Registry. JAMA Intern Med 2014; 174: 1651–1659.
23. Bhatt DL, Eagle KA, Ohman EM. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 2010; 304: 1350–1357.
24. Budaj A, Brieger D, Steg PG. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2003; 146: 999–1006.
25. Solomon MD, Go AS, Shilane D. Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non–ST-segment elevation myocardial infarction. J Am Coll Cardiol 2014; 63: 2249–2257.
26. Peterson ED, Roe MT, Chen AY. The NCDR ACTION Registry-GWTG: Transforming contemporary acute myocardial infarction clinical care. Heart 2010; 96: 1798–1802.